Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENLV | DERM | AVTX | ||
| Company | Enlivex Therapeutics Ltd | Journey Medical Corp | Avalo Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2000 | 8.49 | 13.50 | ||
| High | 1.2001 | 8.53 | 14.45 | ||
| Low | 1.1389 | 8.33 | 13.19 | ||
| Latest | 1.1600 | 8.35 | 14.19 | ||
| Change | unch | unch | +1.04 | ||
| % Change | unch | unch | +7.91% | ||
| Volume | 314,800 | 55,000 | 319,300 | ||
| 20-Day Average Volume | 521,710 | 125,335 | 378,480 | ||
| Previous Close | 1.1600 | 8.35 | 13.15 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0395 | 8.37 | 15.53 | ||
| 20-Day Raw Stochastic | 76.01% | 49.90% | 25.96% | ||
| 20-Day Relative Strength | 60.76 | 52.26 | 42.22 | ||
| Weighted Alpha | +33.00 | +58.63 | +82.76 | ||
| Today's Opinion | 24% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 24% Buy | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Sell | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.85% since 01/30/26 | -0.12% since 01/30/26 | -6.09% since 01/30/26 | ||
| Low | 1.0000 on 02/02/26 | 8.22 on 02/05/26 | 13.04 on 02/05/26 | ||
| High | 1.2600 on 02/05/26 | 8.85 on 02/02/26 | 16.80 on 02/02/26 | ||
| 1-Month | |||||
| %Chg | +41.62% since 01/06/26 | +15.65% since 01/06/26 | -10.78% since 01/06/26 | ||
| Low | 0.8003 on 01/07/26 | 7.15 on 01/12/26 | 13.04 on 02/05/26 | ||
| High | 1.2600 on 02/05/26 | 9.56 on 01/23/26 | 17.72 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +14.85% since 11/06/25 | -9.14% since 11/06/25 | -7.98% since 11/06/25 | ||
| Low | 0.6600 on 12/31/25 | 6.97 on 01/05/26 | 13.04 on 02/05/26 | ||
| High | 1.8100 on 11/24/25 | 9.56 on 01/23/26 | 20.72 on 12/11/25 | ||
| 6-Month | |||||
| %Chg | -14.07% since 08/06/25 | +15.49% since 08/06/25 | +70.76% since 08/06/25 | ||
| Low | 0.6600 on 12/31/25 | 6.67 on 08/13/25 | 8.01 on 08/07/25 | ||
| High | 2.1000 on 08/15/25 | 9.56 on 01/23/26 | 20.72 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 275,363 | 277,696 | 262,699 | ||
| Shares Outstanding, K | 237,382 | 33,257 | 18,513 | ||
| Annual Sales | 0 | 56,130,000 | 440,000 | ||
| Annual Net Income | -15,010,000 | -14,670,000 | -35,130,000 | ||
| Last Quarter Sales | 0 | 17,630,000 | 0 | ||
| Last Quarter Net Income | -2,210,000 | -2,320,000 | -30,630,000 | ||
| 60-Month Beta | 1.63 | 0.81 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 11/14/25 | -0.09 on 11/12/25 | -2.19 on 11/06/25 | ||
| Latest Earnings Date | 03/30/26 | 03/25/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||